Table 1

Outcome measures throughout the study

InclusionFirst evaluationMid-programme evaluationEnd of programme evaluationFirst follow-up evaluationSecond follow-up evaluationDuring 8 weeks
Visit 1Visit 2Visit 3Visit 4Visit 5Visit 6
Week 4Week 8Week 12Week 16
Eligibility criteria✕
Medical evaluation✕✕✕✕✕✕
Gait Speed 10MWT
(speed, m/s)		✕✕✕✕✕
Gait performance 2mWT (distance, m)✕✕✕✕✕
3D Gait Analysis✕✕
Lower limb strength (MRC/60)✕✕✕✕✕✕
Maximal Voluntary Contraction
Ankle dorsiflexors (Force/Nm)		✕✕✕✕✕
Lower limb spasticity (MAS/20)✕✕✕✕✕
Lower limb function
(FMA-LE/34)		✕✕✕✕✕
Questionnaires (ABILOCO, FACIT, Barthel)✕✕✕✕✕
H-reflex/M-wave (%)✕✕✕✕✕
Voluntary activation (%)✕✕✕✕✕
TA 100 Hz FMV/Sham FMV
(5×30 min/week)		✕
Conventional rehabilitation✕

  • Red cross is indicated for the main outcome and blue ones for secondary outcomes.

  • ABILOCO, locomotion ability measure; 3D, three dimensions; FACIT, Functional Assessment of Chronic Illness Therapy; FMA-LE, Fugl-Meyer assessment of lower extremity; FMV, focal muscular vibration; MAS, modified Ashworth scale; MRC, Medical Research Council; 2mWT, 2 min walking test; 10MWT, 10 m walking test; Nm, Newton metre; TA, tibialis anterior.